Celanese EVA Performance Polymers has invited pharmaceutical industry to participate in dialogue around ethylene vinyl acetate (EVA) polymer technology with the introduction of its new blog at VitalDose.com/blog. Dr Ken Anderson, a polymer research and technical service, will be covering topics ranging from technical information and polymer processing to pharma applications and industry news.
“Ethylene vinyl acetate (EVA) polymers have been utilized for many years in the pharmaceutical world for drug delivery applications. Our new blog will highlight EVA polymers as excipients as we seek to inform the pharmaceutical world about this polymer and its uses,” said Anderson. Celanese invites everyone from students to seasoned research professionals to take part in the discussion. “We look forward to participation from all aspects of the industry including research and development scientists in contract research and contract manufacturing organizations, small and start-up companies, large pharmaceutical companies, and academia,” he said.
Celanese manufactures VitalDose EVA polymers for use in drug delivery. The blog can be found as part of the VitalDose website at www.VitalDose.com/blog.
Celanese EVA Performance Polymers will highlight the new blog while exhibiting at the Controlled Release Society, from July 15-18 in Quebec City, Canada.
The business is a North American leader in developing products and application technology to improve performance, create value and drive innovation in a broad range of industrial and consumer end-use applications including flexible packaging, thermal lamination film, hot melt adhesive, USP class VI medical products and photovoltaic cells. The business has manufacturing facilities in Edmonton, Canada, and is supported by expert technical service.
Celanese Corporation is a global technology leader in the production of specialty materials and chemical products which are used in most major industries and consumer applications.